Company

Aurobindo Pharma Signs Pact With Singapore Based Hilleman Labs For Children Vaccine

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Categories

All Quarterly Result Economy Mutual Fund Business Company Market Budget IPO

Aurobindo Pharma signs pact with Singapore-based Hilleman Labs for children vaccine

Sep 28, 2023

By: BlinkX Research Team

Aurobindo Pharma Limited's wholly-owned subsidiary Auro Vaccines Private Limited on Wednesday informed that it has entered into a licence agreement with Hilleman Laboratories Singapore Pte. Limited.

According to the filing, the agreement is about developing, manufacturing and commercializing a pentavalent vaccine candidate used in children vaccination.

Auro Vaccines Private Limited will make milestone payments to Hilleman upon achieving certain development and clinical study outcomes. Hilleman will also be paid royalties upon commercialization of the vaccine candidate, the company said in a statement.

Shares of Aurobindo Pharma were under pressure in the morning session due to market volatility and trading at Rs876 per share lower by 0.47% on the BSE today.